(Q37657483)

21 August 2017

1 reference

title

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (English)

1 reference

21 August 2017

1 reference

Jorge H Milone

1

1 reference

PubMed ID

20017606

21 August 2017

Alicia Enrico

series ordinal

2

1 reference

21 August 2017

1 December 2009

1 reference

21 August 2017

1 reference

21 August 2017

50 Suppl 2

1 reference

21 August 2017

9-15

1 reference

BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations

21 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

The biology and therapy of adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Childhood and adolescent lymphoid and myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Molecular genetics of acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Novel agents in CML therapy: tyrosine kinase inhibitors and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903370395

10.3109/10428190903370395

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

20017606